242 related articles for article (PubMed ID: 37110302)
1. Gut Dysbiosis: A Target for Protective Interventions against Parkinson's Disease.
Lima IS; Pêgo AC; Martins AC; Prada AR; Barros JT; Martins G; Gozzelino R
Microorganisms; 2023 Mar; 11(4):. PubMed ID: 37110302
[TBL] [Abstract][Full Text] [Related]
2. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
[TBL] [Abstract][Full Text] [Related]
3. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
[TBL] [Abstract][Full Text] [Related]
4. Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson's disease.
Bhattarai Y; Si J; Pu M; Ross OA; McLean PJ; Till L; Moor W; Grover M; Kandimalla KK; Margolis KG; Farrugia G; Kashyap PC
Gut Microbes; 2021 Jan; 13(1):1866974. PubMed ID: 33459114
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
Guo TT; Zhang Z; Sun Y; Zhu RY; Wang FX; Ma LJ; Jiang L; Liu HD
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839287
[TBL] [Abstract][Full Text] [Related]
6. Intestinal Barrier Dysfunction in the Absence of Systemic Inflammation Fails to Exacerbate Motor Dysfunction and Brain Pathology in a Mouse Model of Parkinson's Disease.
Jackson A; Engen PA; Forsyth CB; Shaikh M; Naqib A; Wilber S; Frausto DM; Raeisi S; Green SJ; Bradaric BD; Persons AL; Voigt RM; Keshavarzian A
Front Neurol; 2022; 13():882628. PubMed ID: 35665034
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
8. Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice.
Perez-Pardo P; Dodiya HB; Engen PA; Forsyth CB; Huschens AM; Shaikh M; Voigt RM; Naqib A; Green SJ; Kordower JH; Shannon KM; Garssen J; Kraneveld AD; Keshavarzian A
Gut; 2019 May; 68(5):829-843. PubMed ID: 30554160
[TBL] [Abstract][Full Text] [Related]
9. Dual-Hit Model of Parkinson's Disease: Impact of Dysbiosis on 6-Hydroxydopamine-Insulted Mice-Neuroprotective and Anti-Inflammatory Effects of Butyrate.
Avagliano C; Coretti L; Lama A; Pirozzi C; De Caro C; De Biase D; Turco L; Mollica MP; Paciello O; Calignano A; Meli R; Lembo F; Mattace Raso G
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742813
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease.
Zhu M; Liu X; Ye Y; Yan X; Cheng Y; Zhao L; Chen F; Ling Z
Front Immunol; 2022; 13():937555. PubMed ID: 35812394
[TBL] [Abstract][Full Text] [Related]
11. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
Nielsen SD; Pearson NM; Seidler K
Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
[TBL] [Abstract][Full Text] [Related]
12. Unravelling the role of gut microbiota in Parkinson's disease progression: Pathogenic and therapeutic implications.
Rani L; Mondal AC
Neurosci Res; 2021 Jul; 168():100-112. PubMed ID: 33417973
[TBL] [Abstract][Full Text] [Related]
13. Small Intestinal Bacterial Overgrowth as Potential Therapeutic Target in Parkinson's Disease.
Dănău A; Dumitrescu L; Lefter A; Tulbă D; Popescu BO
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769091
[TBL] [Abstract][Full Text] [Related]
14. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
[TBL] [Abstract][Full Text] [Related]
15. Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant.
Liu R; Kang JD; Sartor RB; Sikaroodi M; Fagan A; Gavis EA; Zhou H; Hylemon PB; Herzog JW; Li X; Lippman RH; Gonzalez-Maeso J; Wade JB; Ghosh S; Gurley E; Gillevet PM; Bajaj JS
Hepatology; 2020 Feb; 71(2):611-626. PubMed ID: 31220352
[TBL] [Abstract][Full Text] [Related]
16. Human gut microbiota and Parkinson's disease.
Pant A; Bisht KS; Aggarwal S; Maiti TK
Prog Mol Biol Transl Sci; 2022; 192(1):281-307. PubMed ID: 36280322
[TBL] [Abstract][Full Text] [Related]
17. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
18. Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson's disease.
Jang JH; Yeom MJ; Ahn S; Oh JY; Ji S; Kim TH; Park HJ
Brain Behav Immun; 2020 Oct; 89():641-655. PubMed ID: 32827699
[TBL] [Abstract][Full Text] [Related]
19. Urolithins: potential biomarkers of gut dysbiosis and disease stage in Parkinson's patients.
Romo-Vaquero M; Fernández-Villalba E; Gil-Martinez AL; Cuenca-Bermejo L; Espín JC; Herrero MT; Selma MV
Food Funct; 2022 Jun; 13(11):6306-6316. PubMed ID: 35611932
[TBL] [Abstract][Full Text] [Related]
20. Disease mechanisms as subtypes: Microbiome.
Bonvegna S; Cilia R
Handb Clin Neurol; 2023; 193():107-131. PubMed ID: 36803806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
